Pfizer-BioNTech Covid-19 vaccine 90.7% effective on children 5-11 years old

The Independent
Sat, 23 Oct 2021 23:00:50 +0000
COVID 19, Featured News, International, booster shot, children, COVID-19, Moderna, Pfizer-BioNTech, vaccine

New York – Pfizer announced on Friday (Oct 22) that its Covid-19 vaccine made with BioNTech showed 90.7 per cent efficacy in a clinical trial involving children aged five to 11 years old. Details of the clinical trial were published ahead of a scheduled panel meeting of experts on Tuesday (Oct 26) whether to recommend …